Development of a Rapid, Antimicrobial Susceptibility Test for E. coli Based on Low-Cost, Screen-Printed Electrodes.
Stuart HannahAlexandra DobreaPerrine LasserreEwen O BlairDavid AlcornPaul A HoskissonDamion K CorriganPublished in: Biosensors (2020)
Antibiotic resistance has been cited by the World Health Organisation (WHO) as one of the greatest threats to public health. Mitigating the spread of antibiotic resistance requires a multipronged approach with possible interventions including faster diagnostic testing and enhanced antibiotic stewardship. This study employs a low-cost diagnostic sensor test to rapidly pinpoint the correct antibiotic for treatment of infection. The sensor comprises a screen-printed gold electrode, modified with an antibiotic-seeded hydrogel to monitor bacterial growth. Electrochemical growth profiles of the common microorganism, Escherichia coli (E. coli) (ATCC 25922) were measured in the presence and absence of the antibiotic streptomycin. Results show a clear distinction between the E. coli growth profiles depending on whether streptomycin is present, in a timeframe of ≈2.5 h (p < 0.05), significantly quicker than the current gold standard of culture-based antimicrobial susceptibility testing. These results demonstrate a clear pathway to a low cost, phenotypic and reproducible antibiotic susceptibility testing technology for the rapid detection of E. coli within clinically relevant concentration ranges for conditions such as urinary tract infections.
Keyphrases
- low cost
- escherichia coli
- public health
- urinary tract infection
- high throughput
- gold nanoparticles
- mental health
- drug delivery
- physical activity
- mass spectrometry
- high resolution
- social media
- pseudomonas aeruginosa
- cystic fibrosis
- health information
- combination therapy
- global health
- single cell
- wound healing
- reduced graphene oxide
- solid state
- tandem mass spectrometry
- simultaneous determination
- molecularly imprinted
- health promotion